ArticleInternational journal of molecular sciences2023

The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer.

Małgorzata Lasota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.